2004
DOI: 10.1136/bmj.329.7478.1333
|View full text |Cite
|
Sign up to set email alerts
|

Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0
3

Year Published

2005
2005
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 17 publications
0
10
0
3
Order By: Relevance
“…It is one of the serious side effects of SSRI. Patients who have a similar presentation makes it difficult to be distinguished from NMS 66. Milestones that characterize serotonin syndrome are shivering, hyperreflexia, myoclonus, and ataxia 67,68.…”
Section: Clinical Features Of the Neuroleptic Syndromementioning
confidence: 99%
“…It is one of the serious side effects of SSRI. Patients who have a similar presentation makes it difficult to be distinguished from NMS 66. Milestones that characterize serotonin syndrome are shivering, hyperreflexia, myoclonus, and ataxia 67,68.…”
Section: Clinical Features Of the Neuroleptic Syndromementioning
confidence: 99%
“…Concomitant use of lithium, other psychotropic drugs, higher potency agents, depot formulations, comorbid substance abuse or neurologic disease, and acute medical illness (including trauma, surgery, and infection) are other commonly listed risk factors that have not been substantiated in casecontrol studies [36,37]. Dehydration present in 92% of patients is a risk factor for NMS as well as an early complication of NMS, but this is not clear [38].…”
Section: Discussionmentioning
confidence: 99%
“…So if mild cases are going undetected that is a semantic issue (serotonergic side effects vs mild ST) of minor consequence, not a major concern about serious or life-threatening adverse events. The main lesson is the same as in Haddow's much criticized report 18 : side effects are more common and less typical in the aged, so minimize the administration of above average doses to the frail elderly. …”
Section: Misleading Casesmentioning
confidence: 99%